La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials

Identifieur interne : 000699 ( Pmc/Curation ); précédent : 000698; suivant : 000700

Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials

Auteurs : Olivier Godefroy [France] ; Laura Gibbons [États-Unis] ; Momar Diouf [France] ; David Nyenhuis [États-Unis] ; Martine Roussel [France] ; Sandra Black [Canada] ; Jean Marc Bugnicourt [France]

Source :

RBID : PMC:4737650

Abstract

Introduction

Although accurate diagnosis of deficit of mild intensity is critical, various methods are used to assess, dichotomize and integrate performance, with no validated gold standard. This study described and validated a framework for the analysis of cognitive performance.

Methods

This study was performed by using the GREFEX database (724 controls and 461 patients) examined by 7 tests assessing executive functions. The first phase determined the criteria for the cutoff scores, the second phase, the effect of test number on diagnostic accuracy and the third phase, the best methods for combining test scores into an overall summary score. Four validation criteria were used: determination of impaired performance as compared to expected one, false-positive rate ≤5%, detection of both single and multiple impairments with optimal sensitivity.

Results

The procedure based on 5th percentile cutoffs determined from standardized residuals was the most appropriate procedure. Although AUC increased with the number of scores (p=.0001), the false-positive rate also increased (p=.0001), resulting in suboptimal sensitivity for detecting selective impairment. Two overall summary scores, the average of the seven process scores and the IRT score, had significantly (p=.0001) higher AUCs, even for patients with a selective impairment, and provided higher resulting prevalence of dysexecutive disorders (p=.0001).

Conclusions

The present study provides and validates a generative framework for the interpretation of cognitive data. Two overall summary score met all 3 validation criteria. A practical consequence is the need to profoundly modify the analysis and interpretation of cognitive assessments for both routine use and clinical research.


Url:
DOI: 10.1016/j.cortex.2014.01.016
PubMed: 24632464
PubMed Central: 4737650

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:4737650

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials</title>
<author>
<name sortKey="Godefroy, Olivier" sort="Godefroy, Olivier" uniqKey="Godefroy O" first="Olivier" last="Godefroy">Olivier Godefroy</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gibbons, Laura" sort="Gibbons, Laura" uniqKey="Gibbons L" first="Laura" last="Gibbons">Laura Gibbons</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Department of General Internal Medicine, University of Washington, Harborview Medical Center, Seattle, WA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of General Internal Medicine, University of Washington, Harborview Medical Center, Seattle, WA</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Diouf, Momar" sort="Diouf, Momar" uniqKey="Diouf M" first="Momar" last="Diouf">Momar Diouf</name>
<affiliation wicri:level="1">
<nlm:aff id="A3">Department of Biostatistics, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Biostatistics, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nyenhuis, David" sort="Nyenhuis, David" uniqKey="Nyenhuis D" first="David" last="Nyenhuis">David Nyenhuis</name>
<affiliation wicri:level="1">
<nlm:aff id="A4">Hauenstein Neuroscience Center, Saint Mary’s Health Care, Grand Rapids, Michigan, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Hauenstein Neuroscience Center, Saint Mary’s Health Care, Grand Rapids, Michigan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Roussel, Martine" sort="Roussel, Martine" uniqKey="Roussel M" first="Martine" last="Roussel">Martine Roussel</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Black, Sandra" sort="Black, Sandra" uniqKey="Black S" first="Sandra" last="Black">Sandra Black</name>
<affiliation wicri:level="1">
<nlm:aff id="A5">Brill Chair in Neurology, Dept of Medicine, Sunnybrook Health Sciences Centre, Toronto. Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Brill Chair in Neurology, Dept of Medicine, Sunnybrook Health Sciences Centre, Toronto. Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bugnicourt, Jean Marc" sort="Bugnicourt, Jean Marc" uniqKey="Bugnicourt J" first="Jean Marc" last="Bugnicourt">Jean Marc Bugnicourt</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24632464</idno>
<idno type="pmc">4737650</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737650</idno>
<idno type="RBID">PMC:4737650</idno>
<idno type="doi">10.1016/j.cortex.2014.01.016</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000699</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000699</idno>
<idno type="wicri:Area/Pmc/Curation">000699</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000699</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials</title>
<author>
<name sortKey="Godefroy, Olivier" sort="Godefroy, Olivier" uniqKey="Godefroy O" first="Olivier" last="Godefroy">Olivier Godefroy</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gibbons, Laura" sort="Gibbons, Laura" uniqKey="Gibbons L" first="Laura" last="Gibbons">Laura Gibbons</name>
<affiliation wicri:level="1">
<nlm:aff id="A2">Department of General Internal Medicine, University of Washington, Harborview Medical Center, Seattle, WA, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of General Internal Medicine, University of Washington, Harborview Medical Center, Seattle, WA</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Diouf, Momar" sort="Diouf, Momar" uniqKey="Diouf M" first="Momar" last="Diouf">Momar Diouf</name>
<affiliation wicri:level="1">
<nlm:aff id="A3">Department of Biostatistics, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Biostatistics, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nyenhuis, David" sort="Nyenhuis, David" uniqKey="Nyenhuis D" first="David" last="Nyenhuis">David Nyenhuis</name>
<affiliation wicri:level="1">
<nlm:aff id="A4">Hauenstein Neuroscience Center, Saint Mary’s Health Care, Grand Rapids, Michigan, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Hauenstein Neuroscience Center, Saint Mary’s Health Care, Grand Rapids, Michigan</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Roussel, Martine" sort="Roussel, Martine" uniqKey="Roussel M" first="Martine" last="Roussel">Martine Roussel</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Black, Sandra" sort="Black, Sandra" uniqKey="Black S" first="Sandra" last="Black">Sandra Black</name>
<affiliation wicri:level="1">
<nlm:aff id="A5">Brill Chair in Neurology, Dept of Medicine, Sunnybrook Health Sciences Centre, Toronto. Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Brill Chair in Neurology, Dept of Medicine, Sunnybrook Health Sciences Centre, Toronto. Ontario</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bugnicourt, Jean Marc" sort="Bugnicourt, Jean Marc" uniqKey="Bugnicourt J" first="Jean Marc" last="Bugnicourt">Jean Marc Bugnicourt</name>
<affiliation wicri:level="1">
<nlm:aff id="A1">Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cortex; a journal devoted to the study of the nervous system and behavior</title>
<idno type="ISSN">0010-9452</idno>
<idno type="eISSN">1973-8102</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>Introduction</title>
<p id="P2">Although accurate diagnosis of deficit of mild intensity is critical, various methods are used to assess, dichotomize and integrate performance, with no validated gold standard. This study described and validated a framework for the analysis of cognitive performance.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">This study was performed by using the GREFEX database (724 controls and 461 patients) examined by 7 tests assessing executive functions. The first phase determined the criteria for the cutoff scores, the second phase, the effect of test number on diagnostic accuracy and the third phase, the best methods for combining test scores into an overall summary score. Four validation criteria were used: determination of impaired performance as compared to expected one, false-positive rate ≤5%, detection of both single and multiple impairments with optimal sensitivity.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">The procedure based on 5
<sup>th</sup>
percentile cutoffs determined from standardized residuals was the most appropriate procedure. Although AUC increased with the number of scores (p=.0001), the false-positive rate also increased (p=.0001), resulting in suboptimal sensitivity for detecting selective impairment. Two overall summary scores, the average of the seven process scores and the IRT score, had significantly (p=.0001) higher AUCs, even for patients with a selective impairment, and provided higher resulting prevalence of dysexecutive disorders (p=.0001).</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P5">The present study provides and validates a generative framework for the interpretation of cognitive data. Two overall summary score met all 3 validation criteria. A practical consequence is the need to profoundly modify the analysis and interpretation of cognitive assessments for both routine use and clinical research.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0100725</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3187</journal-id>
<journal-id journal-id-type="nlm-ta">Cortex</journal-id>
<journal-id journal-id-type="iso-abbrev">Cortex</journal-id>
<journal-title-group>
<journal-title>Cortex; a journal devoted to the study of the nervous system and behavior</journal-title>
</journal-title-group>
<issn pub-type="ppub">0010-9452</issn>
<issn pub-type="epub">1973-8102</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">24632464</article-id>
<article-id pub-id-type="pmc">4737650</article-id>
<article-id pub-id-type="doi">10.1016/j.cortex.2014.01.016</article-id>
<article-id pub-id-type="manuscript">NIHMS753684</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Godefroy</surname>
<given-names>Olivier</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gibbons</surname>
<given-names>Laura</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diouf</surname>
<given-names>Momar</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nyenhuis</surname>
<given-names>David</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roussel</surname>
<given-names>Martine</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Black</surname>
<given-names>Sandra</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bugnicourt</surname>
<given-names>Jean Marc</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<collab>GREFEX study group (
<bold>
<underline>to be listed as Investigators</underline>
</bold>
: O Martinaud, PA Joseph, C Mosca, C Ardouin, D Le Gall, T Meulemans, B Pillon, C Bertola, C Franconie, M Verny, A Bellman, P Azouvi, C Bindschadler, E Bretault, M Vercelletto, F Coyette, P Robert, J de Rotrou, M Leclercq, M Krier)</collab>
<xref rid="FN2" ref-type="author-notes">6</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>
Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France</aff>
<aff id="A3">
<label>3</label>
Department of Biostatistics, University Hospital of Amiens, France</aff>
<aff id="A2">
<label>2</label>
Department of General Internal Medicine, University of Washington, Harborview Medical Center, Seattle, WA, USA</aff>
<aff id="A4">
<label>4</label>
Hauenstein Neuroscience Center, Saint Mary’s Health Care, Grand Rapids, Michigan, USA</aff>
<aff id="A5">
<label>5</label>
Brill Chair in Neurology, Dept of Medicine, Sunnybrook Health Sciences Centre, Toronto. Ontario, Canada</aff>
<author-notes>
<corresp id="FN1">Correspondance: Dr O Godefroy Service de Neurologie CHU Nord 80054 Amiens cedex France. Phone: 33322668240; Fax: 33322668240.
<email>godefroy.olivier@chu-amiens.fr</email>
</corresp>
<fn id="FN2">
<label>6</label>
<p>Groupe de Réflexion sur l’Evaluation des Fonctions Exécutives
<bold>
<italic>(GREFEX) study group</italic>
</bold>
<italic>: the following centers and investigators participated in the GREFEX cooperative study (n= number of patients included at each center; investigators): Amiens University Hospital (F) (n=183; O. Godefroy and M. Roussel), Angers University Hospital (F) (n=19; D. Le Gall), Heliomarin Rehabilitation Center Berck (F) (n=15; C. Bertola), Bordeaux University Hospital (F) (n=28; J.M. Giroire and P.A. Joseph), Saint Luc University Hospital Brussels (B) (n=6; X. Seron, F. Coyette), Cholet General Hospital (F) (n=8; E. Bretault and I. Bernard), Ottignies William Lennox Center (B) (n=3; M. Leclercq), Garches University Hospital (F) (n=9; P. Azouvi and C. Vallat-Azouvi), Grenoble University Hospital (F) (n=24; P Pollack, C Ardouin and C. Mosca), Lausanne University Hospital (CH) (n=9; C Bindschadler), Lay St Christophe Rehabilitation Center (F) (n=3; M. Krier), Liège Department of Cognitive Sciences (B) (n=19; T. Meulemans and V. Marquet), Lille Stroke Center University Hospital (F) (n=26; D. Leys and M. Roussel), Nantes University Hospital (F) (n=8; P. Renou and M. Vercelletto), Nice University Hospital (F) (n=6; E. Michel and P. Robert), Nîmes University Hospital (F) (n=15; P. Labauge and C. Franconie), Paris-La Salpêtrière University Hospital Neurology Department (F) (n=18; B. Pillon and B. Dubois), Paris-La Salpêtrière University Hospital Geriatrics Department (F) (n=13; B. Dieudonnée and M. Verny), Paris-Broca University Hospital (F) (n=5; H. Lenoir and J. De Rotrou), Rouen University Hospital (F) (n=56; D. Hannequin and S. Bioux), Sion Rehabilitation Clinic (CH) (n=12; J. Fuchs, A. Bellmann and P. Vuadens).</italic>
</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>2</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>2</month>
<year>2016</year>
</pub-date>
<volume>54</volume>
<fpage>51</fpage>
<lpage>62</lpage>
<pmc-comment>elocation-id from pubmed: 10.1016/j.cortex.2014.01.016</pmc-comment>
<abstract>
<sec id="S1">
<title>Introduction</title>
<p id="P2">Although accurate diagnosis of deficit of mild intensity is critical, various methods are used to assess, dichotomize and integrate performance, with no validated gold standard. This study described and validated a framework for the analysis of cognitive performance.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">This study was performed by using the GREFEX database (724 controls and 461 patients) examined by 7 tests assessing executive functions. The first phase determined the criteria for the cutoff scores, the second phase, the effect of test number on diagnostic accuracy and the third phase, the best methods for combining test scores into an overall summary score. Four validation criteria were used: determination of impaired performance as compared to expected one, false-positive rate ≤5%, detection of both single and multiple impairments with optimal sensitivity.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">The procedure based on 5
<sup>th</sup>
percentile cutoffs determined from standardized residuals was the most appropriate procedure. Although AUC increased with the number of scores (p=.0001), the false-positive rate also increased (p=.0001), resulting in suboptimal sensitivity for detecting selective impairment. Two overall summary scores, the average of the seven process scores and the IRT score, had significantly (p=.0001) higher AUCs, even for patients with a selective impairment, and provided higher resulting prevalence of dysexecutive disorders (p=.0001).</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P5">The present study provides and validates a generative framework for the interpretation of cognitive data. Two overall summary score met all 3 validation criteria. A practical consequence is the need to profoundly modify the analysis and interpretation of cognitive assessments for both routine use and clinical research.</p>
</sec>
</abstract>
<kwd-group>
<kwd>executive functions</kwd>
<kwd>mild cognitive impairment</kwd>
<kwd>dementia</kwd>
<kwd>stroke</kwd>
<kwd>sensitivity and specificity</kwd>
<kwd>diagnostic accuracy</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000699 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000699 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:4737650
   |texte=   Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:24632464" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022